ABSTRACT
transcranial Doppler Sonography monitors Cerebral Blood Flow of mannitol-treated Patients with Acute large Hemispheric ınfarction

Transkranial Doppler Sonografi Akut Geniş Hemisferik İnfarktüs Nedeniyle Mannitol Tedavisi Gören Hastalarda Serebral Kan Akışını Monitörize Eder
INTRoduCTIoN
Acute large hemispheric infarction usually causes serious brain edema leading to increase in intracranial pressure (ICP), decrease in cerebral perfusion pressure (CPP) and worsening brain ischemia. Experiments and clinical trials have shown that mannitol can attenuate the brain edema, decrease the ICP, and improve the CPP (6, 9, 11) . Mannitol has been widely used in the treatment of cerebral infarction as an osmotic agent. However, the therapeutic effect of mannitol may be compromised when the blood brain barrier is incomplete.
to compare the Vm and PI at different time points. The paired t test was used to compare the bilateral Vm and PI. A value of P<0.05 was considered statistically significant.
RESuLTS
The characteristics and variables at the pre-designed time points are shown in Table I . MABP, HR and SpO 2 remained unchanged during the study period (data not shown).
TCD variables are shown in Table II and Table III . After 125-ml mannitol infusion, the bilateral Vm of MCA elevated significantly from 30 min to 120 min, and reached a peak at 30 min. The PI in the affected hemisphere decreased significantly at 30 min. After 250-ml mannitol infusion, the Vm elevated markedly in the affected hemisphere from 30 min to 120 min and in the unaffected hemisphere from 30 min to 90 min. The Vm reached a maximal level at 30 min. The bilateral PI of MCA decreased dramatically from 30 min to 60 min.
Percentage showed the change of Vm and PI straightly. Figure  1 and 2 are showing the tendencies in Vm% and PI%. After 125-ml mannitol infusion, the Vm% elevated in the affected hemisphere from 30 min to120 min and in the unaffected hemisphere from 30 min to 90 min. The Vm% reached a peak earlier in the affected hemisphere (30min) than in the unaffected hemisphere (60 min). After 250-ml mannitol infusion, the bilateral Vm% of MCA elevated from 30 to 60 min and reached a maximal level at 30 min. The PI% decreased from 30 min to 90 min after 125-ml mannitol infusion and from 30 min to 240 min after 250-ml mannitol infusion. The PI% peaked at 30 min in the affected hemisphere and at 60 min in the unaffected hemisphere. The Vm% and PI% in affected and unaffected hemispheres were comparable.
dISCuSSIoN
Our results showed that the CBF velocity in bilateral MCAs elevated quickly after 125-ml mannitol infusion, and could last 240 min. Although there was no difference in the CBF Mannitol preferentially shrinks the non-infarcted brain causing the worsening of the shift of middle line. Currently, there is controversy on the application of mannitol in the treatment of cerebral infarction due to lack of evidence. To date, the changes in cerebral blood flow (CBF) and ICP after mannitol infusion are still poorly understood. The present study aimed to evaluate the effect of mannitol at different doses (125 ml vs 250 ml) on the CBF and ICP in patients with acute large hemispheric infarction.
SuBjECTS and METHodS
A total of 33 patients with acute large hemispheric infarction were enrolled from the Department of Neurology in Xuanwu Hospital of Capital Medical University. This study was approved by the Ethical Committee of Xuanwu hospital, and written informed consent was obtained from patient's relatives.
Patients were recruited if they had CT or MRI-proven large hemispheric infarction, were admitted within 7 days of onset, were aged 40-85 years, weighed 50-80 kg and had a Glasgow coma scale score of 3-12. The large hemispheric infarction was confirmed when the infarction involved the areas supplied by two or three branches of middle cerebral artery or involved the areas supplied by middle cerebral artery and anterior cerebral artery (1). Patients were excluded if they had a history of carotid stenosis, severely functional disorders of the heart (blood pressure< 90/60mmHg), lung (PaO 2 <60mmHg or PaCO 2 >50mmHg), and kidney (blood creatinine>177µmol/L), or deficient acoustic window.
All the patients underwent neurological evaluation. Consciousness was evaluated with the Glasgow Coma Scale. The detection of blood pressure (BP), heart ratio (HR), pulse oxygen saturation (SpO 2 ) and haematocrit (HCT) as well as blood gas analysis was performed.
All patients received an intravenous bolus infusion of 125 ml of 20% mannitol within 15 min. Six hours later, they received intravenous bolus infusion of 250 ml of 20% mannitol within 30 min. In the six hours before the test any osmotic agent was not used. and Tn refer to variables before and after mannitol infusion. Systolic and diastolic blood pressures were recorded at the time of TCD sonography.
Analysis was performed using the SPSS version 12.0 for Windows. Continuous variables were described as median ± standard deviation (SD). The analysis of variance was applied velocity between the affected hemisphere and unaffected hemisphere, the improvement in the CBF velocity in the affected hemisphere was more evident than in the unaffected hemisphere. CBF velocity in the affected CBF peaked earlier than in the unaffected CBF (30 min vs 60 min). After 250-ml mannitol infusion, the improvement in CBF velocity in the unaffected hemisphere was more obvious than in the affected hemisphere. CBF velocity reached a peak at 30 min in bilateral MCAs. Intravenous mannitol infusion can increase the plasma osmotic pressure (315-320 mOsm/L), elevate the blood volume, decrease the blood viscosity, enhance the erythrocyte deformability and increase the cerebral blood volume (2, 8, 12) . Vm of MCA reflects the CBF. Our findings implied that mannitol could improve the CBF which is important for the improvement of low CPP secondary to acute large hemispheric infarction. When compared with infusion of 250 ml of mannitol, 125-ml mannitol infusion was more beneficial for the improvement of CBF, especially in the affected hemisphere. Thus, 125-ml mannitol is suitable for single bolus infusion aiming to improve CBF.
Our findings showed that the PI of bilateral MCAs decreased from 30 min to 90 min after 125-ml mannitol infusion and from 30 min to 120 min after 250-ml mannitol infusion. After 250-ml mannitol infusion, the decrease in PI in the affected hemisphere was more evident than in the unaffected hemisphere.
Studies have proved the correlation ICP and PI (10, 13) . TCD has been widely used as a non-invasive technique to monitor ICP if the invasive monitoring is difficult or harmful. Our results confirmed that 250-ml mannitol was more powerful to decrease ICP, especially in the affected hemisphere. It has been confirmed in animal experiments that repeated mannitol infusions resulted in a dose-dependent increase in plasma osmolality and a dose-dependent decrease in the percent H 2 O of the ischemic MCA cortex and ipsilateral hemisphere (2) . Acute large hemispheric infarction often leads to malignant brain edema resulting in increase in ICP or even acute herniation of the brain (3). Our results showed that PI decreased after mannitol infusion, especially in the affected hemisphere after 250-ml mannitol infusion. Some studies had shown the adverse effects of mannitol infusion following cerebral infarction. Their explanations are that mannitol can leak from vessels to the brain though the incomplete blood brain barrier leading to the increase in osmotic pressure and decrease the dehydrolysis. In contrast, blood brain barrier of the unaffected hemisphere is complete, and thus dehydrolysis of mannitol is more effective than in the affected hemisphere. The asymmetry of ICP in bilateral hemispheres increase the risk for middle line shift (5, 7, 9, 14) . Our results were not consistent with above findings. Decrease in PI in bilateral MCAs reflects the decrease in ICP. The decrease in PI in the affected hemisphere was greater than in the unaffected hemisphere. Thus, middle line shift was unable to occur after infusion of mannitol at high dose (4). For patients with large hemispheric infarction, both 125-ml and 250-ml mannitol infusion is feasible. The 250-ml mannitol fo bolus infusion is a better choice for patients with malignancy brain edema and signs of brain hernia.
